Department of Urology, Faculty of Medicine, Giresun University, Giresun, Turkey.
Department of Radiology, Faculty of Medicine, Giresun University, Giresun, Turkey.
Abdom Radiol (NY). 2024 Jul;49(7):2305-2310. doi: 10.1007/s00261-024-04288-7. Epub 2024 Apr 23.
Aimed to investigate the role of multiparametric magnetic resonance imaging (mp-MRI) in the diagnosis of granulomatous prostatitis caused by intravesical Bacillus Calmette-Guérin (BCG).
In this prospective, single-center study, 10 male patients who were given intravesical BCG due to intermediate- and high-risk bladder cancer were included. Before transurethral resection of bladder tumors (TURB), all patients were evaluated by mp-MRI, serum prostate-specific antigen (PSA), and digital rectal examination (DRE). Serum PSA levels and DRE findings were evaluated before and after intravesical BCG treatment. Prostate mp-MRI was performed for patients with elevated levels of serum PSA and/or with abnormal DRE findings. Then, MRI fusion + systematic prostate biopsy was performed. Demographic data of the patients before and after intravesical BCG were compared.
The average age of the patients was 66.9 years (55-87 years). While PSA was 1.7 ng/ml before intravesical BCG treatment, it was 4.3 ng/ml after intravesical BCG treatment (p = 0.005). PSA density (PSAD) was 0.04 and 0.10 before and after the treatment, respectively (p = 0.012). DRE findings of all patients were normal before the treatment. However, abnormal findings were detected in 80% of them after the treatment (p = 0.008). PI-RADS ≥ 3 lesions were found to be significantly higher in all patients after intravesical BCG (p = 0.004).
Granulomatous prostatitis is a rare complication of intravesical BCG. High PSA, abnormal DRE, and PI-RADS ≥ 3 lesions detected after intravesical BCG should suggest granulomatous prostatitis and unnecessary biopsies may be avoided.
旨在探讨多参数磁共振成像(mp-MRI)在诊断膀胱内卡介苗(BCG)引起的肉芽肿性前列腺炎中的作用。
在这项前瞻性、单中心研究中,纳入了 10 名因中高危膀胱癌接受膀胱内 BCG 治疗的男性患者。在经尿道膀胱肿瘤切除术(TURB)前,所有患者均接受了 mp-MRI、血清前列腺特异性抗原(PSA)和直肠指检(DRE)检查。在膀胱内 BCG 治疗前后评估血清 PSA 水平和 DRE 结果。对于血清 PSA 水平升高和/或 DRE 结果异常的患者进行前列腺 mp-MRI 检查。然后进行 MRI 融合+系统前列腺活检。比较膀胱内 BCG 治疗前后患者的人口统计学数据。
患者的平均年龄为 66.9 岁(55-87 岁)。膀胱内 BCG 治疗前 PSA 为 1.7ng/ml,治疗后 PSA 为 4.3ng/ml(p=0.005)。治疗前后 PSA 密度(PSAD)分别为 0.04 和 0.10(p=0.012)。治疗前所有患者的 DRE 检查结果均正常,但治疗后 80%的患者出现异常(p=0.008)。膀胱内 BCG 治疗后,所有患者的 PI-RADS≥3 病变明显增多(p=0.004)。
肉芽肿性前列腺炎是膀胱内 BCG 的罕见并发症。膀胱内 BCG 后出现高 PSA、DRE 异常和 PI-RADS≥3 病变应提示肉芽肿性前列腺炎,可避免不必要的活检。